Clinuvel Pharmaceuticals Ltd
ASX:CUV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
Puma SE
XETRA:PUM
|
DE |
|
F
|
First Community Corp (South Carolina)
NASDAQ:FCCO
|
US |
|
NTT Data Corp
TSE:9613
|
JP |
|
Just Eat Takeaway.com NV
AEX:TKWY
|
NL |
|
Lands End Inc
NASDAQ:LE
|
US |
|
M
|
Melrose Industries PLC
OTC:MLSPF
|
UK |
|
Ross Stores Inc
NASDAQ:ROST
|
US |
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
|
Emerson Electric Co
NYSE:EMR
|
US |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
Bird Construction Inc
TSX:BDT
|
CA |
|
J
|
JCDecaux SA
XBER:DCS
|
FR |
|
Abeona Therapeutics Inc
NASDAQ:ABEO
|
US |
|
P
|
Pitney Bowes Inc
F:PBW
|
US |
|
Vulcan Materials Co
NYSE:VMC
|
US |
|
Cigna Corp
NYSE:CI
|
US |
|
Take-Two Interactive Software Inc
BMV:TTWO
|
US |
|
Svenska Cellulosa SCA AB
STO:SCA B
|
SE |
|
Raymond Ltd
NSE:RAYMOND
|
IN |
|
A
|
Andritz AG
VSE:ANDR
|
AT |
|
Storytel AB (publ)
OTC:STRYF
|
SE |
|
D
|
DXC Technology Co
F:2XT
|
US |
|
P
|
Palatin Technologies Inc
LSE:0KF3
|
US |
Wall St Price Targets
CUV Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for CUV is 24.54 AUD with a low forecast of 13.13 AUD and a high forecast of 41.16 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CUV's stock price target?
Price Target
24.54
AUD
According to Wall Street analysts, the average 1-year price target for CUV is 24.54 AUD with a low forecast of 13.13 AUD and a high forecast of 41.16 AUD.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
